Voyager Therapeutics, Inc. (VYGR)

Voyager Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	413	371	236	103	268	517
Market Cap Growth	51.45%	57.67%	128.95%	-61.60%	-48.20%	68.99%
Enterprise Value	13	140	117	-30	87	236
PE Ratio	-	2.81	-5.07	-1.44	7.29	-11.86
PS Ratio	3.47	1.49	5.76	2.75	1.57	4.95
PB Ratio	1.21	1.57	3.99	1.08	1.74	5.20
P/FCF Ratio	50.15	4.97	-15.70	-1.87	-2.46	12.58
P/OCF Ratio	31.46	4.77	-18.83	-1.92	-2.77	10.63
EV/Sales Ratio	0.11	0.56	2.85	-0.79	0.51	2.26
EV/EBITDA Ratio	-11.17	1.11	-2.78	0.45	2.23	-4.98
EV/EBIT Ratio	-7.54	1.15	-2.42	0.42	2.47	-4.71
EV/FCF Ratio	1.61	1.88	-7.78	0.54	-0.80	5.73
Quick Ratio	5.55	4.87	1.64	2.61	7.07	3.95
Current Ratio	5.64	4.96	1.72	2.68	7.39	4.01
Asset Turnover	0.33	0.77	0.22	0.18	0.60	0.27
Interest Coverage	-	-	-	-181.56	-	-
Return on Equity (ROE)	-1.30%	63.90%	-67.50%	-66.30%	30.80%	-40.90%
Return on Assets (ROA)	-0.90%	40.80%	-24.60%	-34.50%	12.80%	-11.40%
Return on Capital (ROIC)	-5.00%	51.09%	-86.14%	-77.45%	17.74%	-51.93%
Earnings Yield	-0.74%	35.64%	-19.71%	-69.21%	13.72%	-8.43%
FCF Yield	1.99%	20.11%	-6.37%	-53.60%	-40.62%	7.95%
Buyback Yield / Dilution	-35.47%	-16.20%	-1.83%	-0.86%	-4.04%	-11.95%
Total Shareholder Return	-35.47%	-16.20%	-1.83%	-0.86%	-4.04%	-11.95%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).